[{"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "GlaxoSmithKline, LLC.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000005449", "Total_Amount_of_Payment_USDollars": "200.00", "Date_of_Payment": "05/14/2014", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "197835004", "Nature_of_Payment_or_Transfer_of_Value": "Consulting Fee", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "TANZEUM", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Sunovion Pharmaceuticals Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "MA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000254", "Total_Amount_of_Payment_USDollars": "97.52", "Date_of_Payment": "10/17/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "163281486", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Brovana", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "AstraZeneca Pharmaceuticals LP", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "DE", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000146", "Total_Amount_of_Payment_USDollars": "76.68", "Date_of_Payment": "02/18/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "150009076", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "SYMBICORT", "Name_of_Associated_Covered_Drug_or_Biological2": "FARXIGA", "Contextual_Information": "Informational Meal"}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Janssen Pharmaceuticals, Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000232", "Total_Amount_of_Payment_USDollars": "74.99", "Date_of_Payment": "06/29/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "275703818", "Nature_of_Payment_or_Transfer_of_Value": "Education", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Xarelto", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": "Medical Textbook"}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "AstraZeneca Pharmaceuticals LP", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "DE", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000146", "Total_Amount_of_Payment_USDollars": "72.81", "Date_of_Payment": "01/05/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "260067018", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "SYMBICORT", "Name_of_Associated_Covered_Drug_or_Biological2": "FARXIGA", "Contextual_Information": "Informational Meal"}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Takeda Pharmaceuticals America, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IL", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000339", "Total_Amount_of_Payment_USDollars": "69.00", "Date_of_Payment": "03/18/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "336914248", "Nature_of_Payment_or_Transfer_of_Value": "Education", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Brintellix", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Pfizer Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NY", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000286", "Total_Amount_of_Payment_USDollars": "29.95", "Date_of_Payment": "07/21/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "322642260", "Nature_of_Payment_or_Transfer_of_Value": "Education", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "PREVNAR - 13", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "GlaxoSmithKline, LLC.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000005449", "Total_Amount_of_Payment_USDollars": "25.00", "Date_of_Payment": "12/04/2015", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "318839365", "Nature_of_Payment_or_Transfer_of_Value": "Consulting Fee", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "BREO", "Name_of_Associated_Covered_Drug_or_Biological2": "ANORO", "Contextual_Information": "Payment was made by a third party for participation in a market research study on behalf of GSK"}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "GlaxoSmithKline, LLC.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000005449", "Total_Amount_of_Payment_USDollars": "25.00", "Date_of_Payment": "03/06/2015", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "318839402", "Nature_of_Payment_or_Transfer_of_Value": "Consulting Fee", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "BREO", "Name_of_Associated_Covered_Drug_or_Biological2": "ANORO", "Contextual_Information": "Payment was made by a third party for participation in a market research study on behalf of GSK"}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "GlaxoSmithKline, LLC.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000005449", "Total_Amount_of_Payment_USDollars": "25.00", "Date_of_Payment": "05/29/2015", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "318839496", "Nature_of_Payment_or_Transfer_of_Value": "Consulting Fee", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "BREO", "Name_of_Associated_Covered_Drug_or_Biological2": "ANORO", "Contextual_Information": "Payment was made by a third party for participation in a market research study on behalf of GSK"}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "GlaxoSmithKline, LLC.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000005449", "Total_Amount_of_Payment_USDollars": "25.00", "Date_of_Payment": "05/01/2015", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "318839548", "Nature_of_Payment_or_Transfer_of_Value": "Consulting Fee", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "BREO", "Name_of_Associated_Covered_Drug_or_Biological2": "ANORO", "Contextual_Information": "Payment was made by a third party for participation in a market research study on behalf of GSK"}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "GlaxoSmithKline, LLC.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000005449", "Total_Amount_of_Payment_USDollars": "25.00", "Date_of_Payment": "04/03/2015", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "318839573", "Nature_of_Payment_or_Transfer_of_Value": "Consulting Fee", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "BREO", "Name_of_Associated_Covered_Drug_or_Biological2": "ANORO", "Contextual_Information": "Payment was made by a third party for participation in a market research study on behalf of GSK"}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Janssen Pharmaceuticals, Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000232", "Total_Amount_of_Payment_USDollars": "24.86", "Date_of_Payment": "02/23/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "275703816", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Xarelto", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Janssen Pharmaceuticals, Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000232", "Total_Amount_of_Payment_USDollars": "23.48", "Date_of_Payment": "12/16/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "156752454", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Invokana", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "E.R. Squibb & Sons, L.L.C.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000005499", "Total_Amount_of_Payment_USDollars": "22.97", "Date_of_Payment": "04/28/2014", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "187868958", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "ELIQUIS", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "AstraZeneca Pharmaceuticals LP", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "DE", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000146", "Total_Amount_of_Payment_USDollars": "22.71", "Date_of_Payment": "09/18/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "148871026", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "BYDUREON WEEKLY", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": "Informational Meal"}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Lilly USA, LLC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IN", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000066", "Total_Amount_of_Payment_USDollars": "22.15", "Date_of_Payment": "09/21/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "268111852", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "HUMALOG", "Name_of_Associated_Covered_Drug_or_Biological2": "TRADJENTA", "Contextual_Information": ""}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Boehringer Ingelheim Pharmaceuticals, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CT", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000234", "Total_Amount_of_Payment_USDollars": "21.73", "Date_of_Payment": "02/27/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "290266412", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "SPIRIVA RESPIMAT", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Boehringer Ingelheim Pharmaceuticals, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CT", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000234", "Total_Amount_of_Payment_USDollars": "20.74", "Date_of_Payment": "05/09/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "196132650", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "SPIRIVA", "Name_of_Associated_Covered_Drug_or_Biological2": "PRADAXA", "Contextual_Information": ""}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "E.R. Squibb & Sons, L.L.C.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000005499", "Total_Amount_of_Payment_USDollars": "20.25", "Date_of_Payment": "07/10/2014", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "187952028", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "ELIQUIS", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "E.R. Squibb & Sons, L.L.C.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000005499", "Total_Amount_of_Payment_USDollars": "20.25", "Date_of_Payment": "06/11/2014", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "187921774", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "ELIQUIS", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "GlaxoSmithKline, LLC.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000005449", "Total_Amount_of_Payment_USDollars": "20.00", "Date_of_Payment": "04/03/2015", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "318839353", "Nature_of_Payment_or_Transfer_of_Value": "Consulting Fee", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "BREO", "Name_of_Associated_Covered_Drug_or_Biological2": "ANORO", "Contextual_Information": "Payment was made by a third party for participation in a market research study on behalf of GSK"}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "GlaxoSmithKline, LLC.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000005449", "Total_Amount_of_Payment_USDollars": "20.00", "Date_of_Payment": "06/05/2015", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "318839384", "Nature_of_Payment_or_Transfer_of_Value": "Consulting Fee", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": "Payment was made by a third party for participation in a market research study on behalf of GSK"}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "GlaxoSmithKline, LLC.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000005449", "Total_Amount_of_Payment_USDollars": "20.00", "Date_of_Payment": "05/08/2015", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "318839420", "Nature_of_Payment_or_Transfer_of_Value": "Consulting Fee", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "BREO", "Name_of_Associated_Covered_Drug_or_Biological2": "ADVAIR", "Contextual_Information": "Payment was made by a third party for participation in a market research study on behalf of GSK"}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "GlaxoSmithKline, LLC.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000005449", "Total_Amount_of_Payment_USDollars": "20.00", "Date_of_Payment": "12/11/2015", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "318839440", "Nature_of_Payment_or_Transfer_of_Value": "Consulting Fee", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "BREO", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": "Payment was made by a third party for participation in a market research study on behalf of GSK"}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "GlaxoSmithKline, LLC.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000005449", "Total_Amount_of_Payment_USDollars": "20.00", "Date_of_Payment": "04/24/2015", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "318839459", "Nature_of_Payment_or_Transfer_of_Value": "Consulting Fee", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "BREO", "Name_of_Associated_Covered_Drug_or_Biological2": "ADVAIR", "Contextual_Information": "Payment was made by a third party for participation in a market research study on behalf of GSK"}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "GlaxoSmithKline, LLC.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000005449", "Total_Amount_of_Payment_USDollars": "20.00", "Date_of_Payment": "03/27/2015", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "318839479", "Nature_of_Payment_or_Transfer_of_Value": "Consulting Fee", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "BREO", "Name_of_Associated_Covered_Drug_or_Biological2": "ADVAIR", "Contextual_Information": "Payment was made by a third party for participation in a market research study on behalf of GSK"}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "GlaxoSmithKline, LLC.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000005449", "Total_Amount_of_Payment_USDollars": "20.00", "Date_of_Payment": "01/30/2015", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "318839510", "Nature_of_Payment_or_Transfer_of_Value": "Consulting Fee", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "BREO", "Name_of_Associated_Covered_Drug_or_Biological2": "ADVAIR", "Contextual_Information": "Payment was made by a third party for participation in a market research study on behalf of GSK"}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "GlaxoSmithKline, LLC.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000005449", "Total_Amount_of_Payment_USDollars": "20.00", "Date_of_Payment": "10/30/2015", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "318839532", "Nature_of_Payment_or_Transfer_of_Value": "Consulting Fee", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "ANORO", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": "Payment was made by a third party for participation in a market research study on behalf of GSK"}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Boehringer Ingelheim Pharmaceuticals, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CT", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000234", "Total_Amount_of_Payment_USDollars": "19.73", "Date_of_Payment": "09/03/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "290266398", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "SPIRIVA RESPIMAT", "Name_of_Associated_Covered_Drug_or_Biological2": "STIOLTO", "Contextual_Information": ""}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Lilly USA, LLC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IN", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000066", "Total_Amount_of_Payment_USDollars": "19.43", "Date_of_Payment": "08/21/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "268111850", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "HUMALOG", "Name_of_Associated_Covered_Drug_or_Biological2": "TRADJENTA", "Contextual_Information": ""}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Takeda Pharmaceuticals America, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IL", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000339", "Total_Amount_of_Payment_USDollars": "19.19", "Date_of_Payment": "12/18/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "337442184", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Nesina", "Name_of_Associated_Covered_Drug_or_Biological2": "Oseni", "Contextual_Information": ""}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Janssen Pharmaceuticals, Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000232", "Total_Amount_of_Payment_USDollars": "18.22", "Date_of_Payment": "03/09/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "275703780", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Xarelto", "Name_of_Associated_Covered_Drug_or_Biological2": "Invokana", "Contextual_Information": ""}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Boehringer Ingelheim Pharmaceuticals, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CT", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000234", "Total_Amount_of_Payment_USDollars": "18.12", "Date_of_Payment": "11/05/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "196132642", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "JARDIANCE", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Lilly USA, LLC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IN", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000066", "Total_Amount_of_Payment_USDollars": "17.79", "Date_of_Payment": "04/23/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "268111848", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "HUMALOG", "Name_of_Associated_Covered_Drug_or_Biological2": "TRADJENTA", "Contextual_Information": ""}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Boehringer Ingelheim Pharmaceuticals, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CT", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000234", "Total_Amount_of_Payment_USDollars": "17.33", "Date_of_Payment": "08/05/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "196132646", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "TRADJENTA", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Boehringer Ingelheim Pharmaceuticals, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CT", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000234", "Total_Amount_of_Payment_USDollars": "17.22", "Date_of_Payment": "12/08/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "290140608", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "SPIRIVA RESPIMAT", "Name_of_Associated_Covered_Drug_or_Biological2": "STIOLTO", "Contextual_Information": ""}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Takeda Pharmaceuticals America, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IL", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000339", "Total_Amount_of_Payment_USDollars": "16.93", "Date_of_Payment": "03/16/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "337041784", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Nesina", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Novo Nordisk Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000144", "Total_Amount_of_Payment_USDollars": "16.82", "Date_of_Payment": "02/24/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "269610912", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Levemir", "Name_of_Associated_Covered_Drug_or_Biological2": "Victoza", "Contextual_Information": ""}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "AstraZeneca Pharmaceuticals LP", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "DE", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000146", "Total_Amount_of_Payment_USDollars": "16.71", "Date_of_Payment": "10/15/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "150361838", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "BYDUREON WEEKLY", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": "Informational Meal"}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "GlaxoSmithKline, LLC.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000005449", "Total_Amount_of_Payment_USDollars": "16.64", "Date_of_Payment": "07/17/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "197802516", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "BREO", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Janssen Pharmaceuticals, Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000232", "Total_Amount_of_Payment_USDollars": "16.55", "Date_of_Payment": "12/07/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "275703752", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "INVOKANA", "Name_of_Associated_Covered_Drug_or_Biological2": "XARELTO", "Contextual_Information": "Related to product discussion"}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Takeda Pharmaceuticals America, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IL", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000339", "Total_Amount_of_Payment_USDollars": "16.42", "Date_of_Payment": "04/27/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "337097212", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Uloric", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Amgen Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000203", "Total_Amount_of_Payment_USDollars": "16.10", "Date_of_Payment": "06/19/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "138219770", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Prolia", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Takeda Pharmaceuticals America, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IL", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000339", "Total_Amount_of_Payment_USDollars": "16.00", "Date_of_Payment": "02/02/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "336847060", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Nesina", "Name_of_Associated_Covered_Drug_or_Biological2": "Oseni", "Contextual_Information": ""}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Astellas Pharma US Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IL", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000137", "Total_Amount_of_Payment_USDollars": "15.58", "Date_of_Payment": "08/09/2013", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "101678684", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Myrbetriq", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "AstraZeneca Pharmaceuticals LP", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "DE", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000146", "Total_Amount_of_Payment_USDollars": "15.54", "Date_of_Payment": "09/08/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "150296152", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "SYMBICORT", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": "Educational Program"}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "AstraZeneca Pharmaceuticals LP", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "DE", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000146", "Total_Amount_of_Payment_USDollars": "15.48", "Date_of_Payment": "01/16/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "260113384", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "FARXIGA", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": "Informational Meal"}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "AstraZeneca Pharmaceuticals LP", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "DE", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000146", "Total_Amount_of_Payment_USDollars": "15.47", "Date_of_Payment": "08/28/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "148865140", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "BYDUREON WEEKLY", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": "Informational Meal"}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Janssen Pharmaceuticals, Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000232", "Total_Amount_of_Payment_USDollars": "15.45", "Date_of_Payment": "06/09/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "156752456", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Invokana", "Name_of_Associated_Covered_Drug_or_Biological2": "Xarelto", "Contextual_Information": ""}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Boehringer Ingelheim Pharmaceuticals, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CT", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000234", "Total_Amount_of_Payment_USDollars": "15.41", "Date_of_Payment": "04/17/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "196132652", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "TRADJENTA", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "AstraZeneca Pharmaceuticals LP", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "DE", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000146", "Total_Amount_of_Payment_USDollars": "15.14", "Date_of_Payment": "04/21/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "260114804", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "FARXIGA", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": "Informational Meal"}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "AstraZeneca Pharmaceuticals LP", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "DE", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000146", "Total_Amount_of_Payment_USDollars": "15.10", "Date_of_Payment": "03/14/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "260126538", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "FARXIGA", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": "Informational Meal"}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Lilly USA, LLC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IN", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000066", "Total_Amount_of_Payment_USDollars": "15.05", "Date_of_Payment": "03/15/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "268111846", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "HUMALOG", "Name_of_Associated_Covered_Drug_or_Biological2": "TRADJENTA", "Contextual_Information": ""}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "AstraZeneca Pharmaceuticals LP", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "DE", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000146", "Total_Amount_of_Payment_USDollars": "14.98", "Date_of_Payment": "10/13/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "148874232", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "SYMBICORT", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": "Informational Meal"}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Takeda Pharmaceuticals America, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IL", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000339", "Total_Amount_of_Payment_USDollars": "14.95", "Date_of_Payment": "06/17/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "337202006", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Brintellix", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Boehringer Ingelheim Pharmaceuticals, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CT", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000234", "Total_Amount_of_Payment_USDollars": "14.92", "Date_of_Payment": "08/18/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "290266402", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "TRADJENTA", "Name_of_Associated_Covered_Drug_or_Biological2": "JARDIANCE", "Contextual_Information": ""}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "AstraZeneca Pharmaceuticals LP", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "DE", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000146", "Total_Amount_of_Payment_USDollars": "14.82", "Date_of_Payment": "07/21/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "148242732", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": "Informational Meal"}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Boehringer Ingelheim Pharmaceuticals, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CT", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000234", "Total_Amount_of_Payment_USDollars": "14.79", "Date_of_Payment": "12/14/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "290266390", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "JARDIANCE", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "GlaxoSmithKline, LLC.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000005449", "Total_Amount_of_Payment_USDollars": "14.77", "Date_of_Payment": "10/09/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "197816130", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Novo Nordisk Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000144", "Total_Amount_of_Payment_USDollars": "14.76", "Date_of_Payment": "08/25/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "161863176", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "NovoLog", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "AstraZeneca Pharmaceuticals LP", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "DE", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000146", "Total_Amount_of_Payment_USDollars": "14.73", "Date_of_Payment": "06/17/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "150150929", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "BYDUREON", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": "Informational Meal"}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Janssen Pharmaceuticals, Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000232", "Total_Amount_of_Payment_USDollars": "14.70", "Date_of_Payment": "08/07/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "156752462", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Invokana", "Name_of_Associated_Covered_Drug_or_Biological2": "Xarelto", "Contextual_Information": ""}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Novo Nordisk Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000144", "Total_Amount_of_Payment_USDollars": "14.69", "Date_of_Payment": "12/05/2013", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "32372604", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Levemir", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "AstraZeneca Pharmaceuticals LP", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "DE", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000146", "Total_Amount_of_Payment_USDollars": "14.62", "Date_of_Payment": "10/26/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "260079028", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "FARXIGA", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": "Informational Meal"}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Novo Nordisk Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000144", "Total_Amount_of_Payment_USDollars": "14.59", "Date_of_Payment": "03/27/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "269638794", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Levemir", "Name_of_Associated_Covered_Drug_or_Biological2": "NovoLog", "Contextual_Information": ""}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Novo Nordisk Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000144", "Total_Amount_of_Payment_USDollars": "14.55", "Date_of_Payment": "02/12/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "160897284", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Levemir", "Name_of_Associated_Covered_Drug_or_Biological2": "NovoLog", "Contextual_Information": ""}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "AstraZeneca Pharmaceuticals LP", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "DE", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000146", "Total_Amount_of_Payment_USDollars": "14.51", "Date_of_Payment": "03/31/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "260033964", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "FARXIGA", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": "Informational Meal"}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Novo Nordisk Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000144", "Total_Amount_of_Payment_USDollars": "14.41", "Date_of_Payment": "04/16/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "269703780", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Victoza", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Boehringer Ingelheim Pharmaceuticals, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CT", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000234", "Total_Amount_of_Payment_USDollars": "14.35", "Date_of_Payment": "04/02/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "290266410", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "TRADJENTA", "Name_of_Associated_Covered_Drug_or_Biological2": "JARDIANCE", "Contextual_Information": ""}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "E.R. Squibb & Sons, L.L.C.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000005499", "Total_Amount_of_Payment_USDollars": "14.33", "Date_of_Payment": "09/09/2013", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "13981605", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "BYDUREON", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "GlaxoSmithKline, LLC.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000005449", "Total_Amount_of_Payment_USDollars": "14.13", "Date_of_Payment": "11/13/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "318839274", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "ANORO", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Pfizer Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NY", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000286", "Total_Amount_of_Payment_USDollars": "14.08", "Date_of_Payment": "10/19/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "323705070", "Nature_of_Payment_or_Transfer_of_Value": "Education", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "LYRICA", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Pfizer Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NY", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000286", "Total_Amount_of_Payment_USDollars": "14.08", "Date_of_Payment": "11/30/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "323331994", "Nature_of_Payment_or_Transfer_of_Value": "Education", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "LYRICA", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Pfizer Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NY", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000286", "Total_Amount_of_Payment_USDollars": "14.08", "Date_of_Payment": "09/30/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "323760562", "Nature_of_Payment_or_Transfer_of_Value": "Education", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "LYRICA", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Boehringer Ingelheim Pharmaceuticals, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CT", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000234", "Total_Amount_of_Payment_USDollars": "14.07", "Date_of_Payment": "12/12/2013", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "104394396", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "PRADAXA", "Name_of_Associated_Covered_Drug_or_Biological2": "COMBIVENT RESPIMAT", "Contextual_Information": ""}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Sunovion Pharmaceuticals Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "MA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000254", "Total_Amount_of_Payment_USDollars": "14.01", "Date_of_Payment": "12/06/2013", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "101237092", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Brovana", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Sunovion Pharmaceuticals Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "MA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000254", "Total_Amount_of_Payment_USDollars": "13.89", "Date_of_Payment": "06/20/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "163240748", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Brovana", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Boehringer Ingelheim Pharmaceuticals, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CT", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000234", "Total_Amount_of_Payment_USDollars": "13.73", "Date_of_Payment": "05/26/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "290266406", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "GLYXAMBI", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "AstraZeneca Pharmaceuticals LP", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "DE", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000146", "Total_Amount_of_Payment_USDollars": "13.66", "Date_of_Payment": "09/17/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "150811710", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": "Informational Meal"}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "AstraZeneca Pharmaceuticals LP", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "DE", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000146", "Total_Amount_of_Payment_USDollars": "13.61", "Date_of_Payment": "06/18/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "149823972", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "FARXIGA", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": "Informational Meal"}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "SANOFI-AVENTIS U.S. LLC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000076", "Total_Amount_of_Payment_USDollars": "13.61", "Date_of_Payment": "08/18/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "188745746", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "LANTUS", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Amgen Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000203", "Total_Amount_of_Payment_USDollars": "13.59", "Date_of_Payment": "04/09/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "297813600", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Prolia", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Boehringer Ingelheim Pharmaceuticals, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CT", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000234", "Total_Amount_of_Payment_USDollars": "13.57", "Date_of_Payment": "12/04/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "196132638", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "SPIRIVA", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "E.R. Squibb & Sons, L.L.C.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000005499", "Total_Amount_of_Payment_USDollars": "13.44", "Date_of_Payment": "01/07/2014", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "187704488", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "BYDUREON", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Astellas Pharma US Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IL", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000137", "Total_Amount_of_Payment_USDollars": "13.36", "Date_of_Payment": "12/01/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "168872918", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Myrbetriq", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Boehringer Ingelheim Pharmaceuticals, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CT", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000234", "Total_Amount_of_Payment_USDollars": "13.33", "Date_of_Payment": "11/11/2013", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "104381678", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "SPIRIVA", "Name_of_Associated_Covered_Drug_or_Biological2": "PRADAXA", "Contextual_Information": ""}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "AstraZeneca Pharmaceuticals LP", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "DE", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000146", "Total_Amount_of_Payment_USDollars": "13.33", "Date_of_Payment": "04/05/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "150017466", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "SYMBICORT", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": "Informational Meal"}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Boehringer Ingelheim Pharmaceuticals, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CT", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000234", "Total_Amount_of_Payment_USDollars": "13.23", "Date_of_Payment": "06/17/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "196132648", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "PRADAXA", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Novo Nordisk Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000144", "Total_Amount_of_Payment_USDollars": "13.23", "Date_of_Payment": "07/10/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "269793228", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "NovoLog", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Boehringer Ingelheim Pharmaceuticals, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CT", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000234", "Total_Amount_of_Payment_USDollars": "13.22", "Date_of_Payment": "10/15/2013", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "104379530", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "SPIRIVA", "Name_of_Associated_Covered_Drug_or_Biological2": "PRADAXA", "Contextual_Information": ""}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Sunovion Pharmaceuticals Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "MA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000254", "Total_Amount_of_Payment_USDollars": "13.22", "Date_of_Payment": "01/23/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "321153416", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Brovana", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "GlaxoSmithKline, LLC.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000005449", "Total_Amount_of_Payment_USDollars": "13.19", "Date_of_Payment": "05/05/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "318839161", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "ANORO", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Boehringer Ingelheim Pharmaceuticals, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CT", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000234", "Total_Amount_of_Payment_USDollars": "13.17", "Date_of_Payment": "09/16/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "196132644", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "SPIRIVA", "Name_of_Associated_Covered_Drug_or_Biological2": "PRADAXA", "Contextual_Information": ""}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Purdue Pharma L.P.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CT", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000005432", "Total_Amount_of_Payment_USDollars": "12.75", "Date_of_Payment": "11/21/2015", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "251145552", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "HYSINGLA ER", "Name_of_Associated_Covered_Drug_or_Biological2": "BUTRANS", "Contextual_Information": ""}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Novo Nordisk Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000144", "Total_Amount_of_Payment_USDollars": "12.70", "Date_of_Payment": "01/13/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "269549418", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "NovoLog", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Sunovion Pharmaceuticals Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "MA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000254", "Total_Amount_of_Payment_USDollars": "12.68", "Date_of_Payment": "03/21/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "163257594", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Brovana", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "AstraZeneca Pharmaceuticals LP", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "DE", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000146", "Total_Amount_of_Payment_USDollars": "12.65", "Date_of_Payment": "03/17/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "148774148", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "FARXIGA", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": "Informational Meal"}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "GlaxoSmithKline, LLC.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000005449", "Total_Amount_of_Payment_USDollars": "12.65", "Date_of_Payment": "11/01/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "197818810", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "ANORO", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Iroko Pharmaceuticals, LLC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "PA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000011114", "Total_Amount_of_Payment_USDollars": "12.60", "Date_of_Payment": "05/21/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "227843908", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "ZORVOLEX", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "GlaxoSmithKline, LLC.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000005449", "Total_Amount_of_Payment_USDollars": "12.59", "Date_of_Payment": "05/29/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "197793206", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "ANORO", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Novo Nordisk Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000144", "Total_Amount_of_Payment_USDollars": "12.58", "Date_of_Payment": "08/25/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "269956084", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Levemir", "Name_of_Associated_Covered_Drug_or_Biological2": "Victoza", "Contextual_Information": ""}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Pfizer Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NY", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000286", "Total_Amount_of_Payment_USDollars": "12.49", "Date_of_Payment": "07/22/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "323905870", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "TRUMENBA", "Name_of_Associated_Covered_Drug_or_Biological2": "PREVNAR - 13", "Contextual_Information": ""}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Boehringer Ingelheim Pharmaceuticals, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CT", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000234", "Total_Amount_of_Payment_USDollars": "12.45", "Date_of_Payment": "02/21/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "196132656", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "TRADJENTA", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Novo Nordisk Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000144", "Total_Amount_of_Payment_USDollars": "12.39", "Date_of_Payment": "03/19/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "160937426", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Levemir", "Name_of_Associated_Covered_Drug_or_Biological2": "Victoza", "Contextual_Information": ""}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Boehringer Ingelheim Pharmaceuticals, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CT", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000234", "Total_Amount_of_Payment_USDollars": "12.39", "Date_of_Payment": "11/18/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "196132640", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "SPIRIVA", "Name_of_Associated_Covered_Drug_or_Biological2": "PRADAXA", "Contextual_Information": ""}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Janssen Pharmaceuticals, Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000232", "Total_Amount_of_Payment_USDollars": "12.35", "Date_of_Payment": "08/17/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "275703804", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Xarelto", "Name_of_Associated_Covered_Drug_or_Biological2": "Invokana", "Contextual_Information": "Related to product discussion"}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "SHIONOGI INC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000005589", "Total_Amount_of_Payment_USDollars": "12.24", "Date_of_Payment": "09/26/2013", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "103378298", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Osphena", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Astellas Pharma US Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IL", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000137", "Total_Amount_of_Payment_USDollars": "12.16", "Date_of_Payment": "03/20/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "168614600", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Myrbetriq", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Novo Nordisk Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000144", "Total_Amount_of_Payment_USDollars": "12.13", "Date_of_Payment": "08/26/2013", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "32372605", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "NovoLog", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "AstraZeneca Pharmaceuticals LP", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "DE", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000146", "Total_Amount_of_Payment_USDollars": "12.11", "Date_of_Payment": "04/24/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "150538818", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "BYDUREON", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": "Informational Meal"}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Boehringer Ingelheim Pharmaceuticals, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CT", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000234", "Total_Amount_of_Payment_USDollars": "12.08", "Date_of_Payment": "02/20/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "290140610", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "SPIRIVA", "Name_of_Associated_Covered_Drug_or_Biological2": "SPIRIVA RESPIMAT", "Contextual_Information": ""}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Boehringer Ingelheim Pharmaceuticals, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CT", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000234", "Total_Amount_of_Payment_USDollars": "12.05", "Date_of_Payment": "12/17/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "290266388", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "STIOLTO", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Novo Nordisk Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000144", "Total_Amount_of_Payment_USDollars": "12.04", "Date_of_Payment": "03/17/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "269652216", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "NovoLog", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Janssen Pharmaceuticals, Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000232", "Total_Amount_of_Payment_USDollars": "11.94", "Date_of_Payment": "10/23/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "156752470", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Xarelto", "Name_of_Associated_Covered_Drug_or_Biological2": "Invokana", "Contextual_Information": ""}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "AstraZeneca Pharmaceuticals LP", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "DE", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000146", "Total_Amount_of_Payment_USDollars": "11.92", "Date_of_Payment": "03/28/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "148707982", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "SYMBICORT", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": "Informational Meal"}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Boehringer Ingelheim Pharmaceuticals, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CT", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000234", "Total_Amount_of_Payment_USDollars": "11.82", "Date_of_Payment": "09/28/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "290266396", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "GLYXAMBI", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "AstraZeneca Pharmaceuticals LP", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "DE", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000146", "Total_Amount_of_Payment_USDollars": "11.81", "Date_of_Payment": "05/22/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "150702402", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "FARXIGA", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": "Informational Meal"}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "AstraZeneca Pharmaceuticals LP", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "DE", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000146", "Total_Amount_of_Payment_USDollars": "11.81", "Date_of_Payment": "12/15/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "148469052", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "FARXIGA", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": "Educational Program"}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Janssen Pharmaceuticals, Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000232", "Total_Amount_of_Payment_USDollars": "11.81", "Date_of_Payment": "06/15/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "275703798", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Xarelto", "Name_of_Associated_Covered_Drug_or_Biological2": "Invokana", "Contextual_Information": ""}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Novo Nordisk Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000144", "Total_Amount_of_Payment_USDollars": "11.71", "Date_of_Payment": "07/16/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "161651804", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Levemir", "Name_of_Associated_Covered_Drug_or_Biological2": "Victoza", "Contextual_Information": ""}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Novo Nordisk Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000144", "Total_Amount_of_Payment_USDollars": "11.71", "Date_of_Payment": "04/25/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "269713538", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "NovoLog", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Novo Nordisk Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000144", "Total_Amount_of_Payment_USDollars": "11.69", "Date_of_Payment": "04/25/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "161150758", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Levemir", "Name_of_Associated_Covered_Drug_or_Biological2": "Victoza", "Contextual_Information": ""}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "AstraZeneca Pharmaceuticals LP", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "DE", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000146", "Total_Amount_of_Payment_USDollars": "11.69", "Date_of_Payment": "04/17/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "260073130", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "SYMBICORT", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": "Informational Meal"}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Novo Nordisk Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000144", "Total_Amount_of_Payment_USDollars": "11.66", "Date_of_Payment": "10/20/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "270094980", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Victoza", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Daiichi Sankyo Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000195", "Total_Amount_of_Payment_USDollars": "11.63", "Date_of_Payment": "04/16/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "325938564", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Benicar", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Astellas Pharma US Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IL", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000137", "Total_Amount_of_Payment_USDollars": "11.50", "Date_of_Payment": "02/06/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "168647206", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Myrbetriq", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Boehringer Ingelheim Pharmaceuticals, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CT", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000234", "Total_Amount_of_Payment_USDollars": "11.48", "Date_of_Payment": "11/23/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "290266392", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "PRADAXA", "Name_of_Associated_Covered_Drug_or_Biological2": "PRAXBIND", "Contextual_Information": ""}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Novo Nordisk Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000144", "Total_Amount_of_Payment_USDollars": "11.43", "Date_of_Payment": "05/20/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "161339506", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Levemir", "Name_of_Associated_Covered_Drug_or_Biological2": "Victoza", "Contextual_Information": ""}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Novo Nordisk Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000144", "Total_Amount_of_Payment_USDollars": "11.41", "Date_of_Payment": "03/03/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "160949704", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Levemir", "Name_of_Associated_Covered_Drug_or_Biological2": "NovoLog", "Contextual_Information": ""}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Astellas Pharma US Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IL", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000137", "Total_Amount_of_Payment_USDollars": "11.32", "Date_of_Payment": "09/25/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "168418580", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Myrbetriq", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Sanofi Pasteur Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "PA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000299", "Total_Amount_of_Payment_USDollars": "11.31", "Date_of_Payment": "08/21/2013", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "14690353", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "MENACTRA", "Name_of_Associated_Covered_Drug_or_Biological2": "FLUZONE HIGH DOSE", "Contextual_Information": ""}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "AstraZeneca Pharmaceuticals LP", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "DE", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000146", "Total_Amount_of_Payment_USDollars": "11.22", "Date_of_Payment": "03/10/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "150263068", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "FARXIGA", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": "Informational Meal"}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Pfizer Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NY", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000286", "Total_Amount_of_Payment_USDollars": "11.19", "Date_of_Payment": "08/19/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "322700232", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "TOVIAZ", "Name_of_Associated_Covered_Drug_or_Biological2": "VIAGRA", "Contextual_Information": ""}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Pfizer Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NY", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000286", "Total_Amount_of_Payment_USDollars": "11.15", "Date_of_Payment": "05/28/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "206327686", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "CHANTIX", "Name_of_Associated_Covered_Drug_or_Biological2": "VIAGRA", "Contextual_Information": ""}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Novo Nordisk Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000144", "Total_Amount_of_Payment_USDollars": "11.06", "Date_of_Payment": "08/04/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "161855064", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Victoza", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "GlaxoSmithKline, LLC.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000005449", "Total_Amount_of_Payment_USDollars": "11.03", "Date_of_Payment": "06/14/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "197781166", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "ANORO", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Novo Nordisk Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000144", "Total_Amount_of_Payment_USDollars": "11.01", "Date_of_Payment": "09/22/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "162094646", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "NovoLog", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Amgen Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000203", "Total_Amount_of_Payment_USDollars": "10.98", "Date_of_Payment": "08/20/2013", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "8984161", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Prolia", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Boehringer Ingelheim Pharmaceuticals, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CT", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000234", "Total_Amount_of_Payment_USDollars": "10.98", "Date_of_Payment": "05/01/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "290266408", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "PRADAXA", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Takeda Pharmaceuticals America, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IL", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000339", "Total_Amount_of_Payment_USDollars": "10.96", "Date_of_Payment": "11/21/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "194671532", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Nesina", "Name_of_Associated_Covered_Drug_or_Biological2": "Oseni", "Contextual_Information": ""}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "AstraZeneca Pharmaceuticals LP", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "DE", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000146", "Total_Amount_of_Payment_USDollars": "10.89", "Date_of_Payment": "04/07/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "260035686", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "BYDUREON PEN", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": "Informational Meal"}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Novo Nordisk Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000144", "Total_Amount_of_Payment_USDollars": "10.84", "Date_of_Payment": "03/24/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "160825506", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Victoza", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Novo Nordisk Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000144", "Total_Amount_of_Payment_USDollars": "10.83", "Date_of_Payment": "05/23/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "269729052", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "NovoLog", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "AstraZeneca Pharmaceuticals LP", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "DE", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000146", "Total_Amount_of_Payment_USDollars": "10.80", "Date_of_Payment": "12/17/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "148188210", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "BYDUREON WEEKLY", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": "Informational Meal"}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "SANOFI-AVENTIS U.S. LLC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000076", "Total_Amount_of_Payment_USDollars": "10.67", "Date_of_Payment": "02/27/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "188599272", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "LANTUS", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "SANOFI-AVENTIS U.S. LLC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000076", "Total_Amount_of_Payment_USDollars": "10.64", "Date_of_Payment": "06/03/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "188699576", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "APIDRA", "Name_of_Associated_Covered_Drug_or_Biological2": "LANTUS", "Contextual_Information": ""}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "AstraZeneca Pharmaceuticals LP", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "DE", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000146", "Total_Amount_of_Payment_USDollars": "10.55", "Date_of_Payment": "10/20/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "148329492", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": "Informational Meal"}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Novo Nordisk Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000144", "Total_Amount_of_Payment_USDollars": "10.52", "Date_of_Payment": "11/17/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "162233312", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Levemir", "Name_of_Associated_Covered_Drug_or_Biological2": "Victoza", "Contextual_Information": ""}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Takeda Pharmaceuticals America, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IL", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000339", "Total_Amount_of_Payment_USDollars": "10.43", "Date_of_Payment": "10/06/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "194671528", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Nesina", "Name_of_Associated_Covered_Drug_or_Biological2": "Oseni", "Contextual_Information": ""}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Boehringer Ingelheim Pharmaceuticals, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CT", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000234", "Total_Amount_of_Payment_USDollars": "10.41", "Date_of_Payment": "10/21/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "290266394", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "PRADAXA", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Novo Nordisk Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000144", "Total_Amount_of_Payment_USDollars": "10.40", "Date_of_Payment": "01/28/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "269589660", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Levemir", "Name_of_Associated_Covered_Drug_or_Biological2": "NovoLog", "Contextual_Information": ""}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Janssen Pharmaceuticals, Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000232", "Total_Amount_of_Payment_USDollars": "10.38", "Date_of_Payment": "09/24/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "156752468", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Xarelto", "Name_of_Associated_Covered_Drug_or_Biological2": "Invokana", "Contextual_Information": ""}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Purdue Pharma L.P.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CT", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000005432", "Total_Amount_of_Payment_USDollars": "10.35", "Date_of_Payment": "10/29/2014", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "158293032", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "OXYCONTIN", "Name_of_Associated_Covered_Drug_or_Biological2": "BUTRANS", "Contextual_Information": ""}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Purdue Pharma L.P.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CT", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000005432", "Total_Amount_of_Payment_USDollars": "10.35", "Date_of_Payment": "05/07/2015", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "251076462", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "BUTRANS", "Name_of_Associated_Covered_Drug_or_Biological2": "HYSINGLA ER", "Contextual_Information": ""}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "E.R. Squibb & Sons, L.L.C.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000005499", "Total_Amount_of_Payment_USDollars": "10.24", "Date_of_Payment": "10/29/2013", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "13981606", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "BYDUREON", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "GlaxoSmithKline, LLC.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000005449", "Total_Amount_of_Payment_USDollars": "10.24", "Date_of_Payment": "09/25/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "318839212", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "ANORO", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Boehringer Ingelheim Pharmaceuticals, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CT", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000234", "Total_Amount_of_Payment_USDollars": "10.15", "Date_of_Payment": "09/17/2013", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "104318022", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "PRADAXA", "Name_of_Associated_Covered_Drug_or_Biological2": "COMBIVENT RESPIMAT", "Contextual_Information": ""}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Janssen Pharmaceuticals, Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000232", "Total_Amount_of_Payment_USDollars": "10.13", "Date_of_Payment": "07/23/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "156752458", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Xarelto", "Name_of_Associated_Covered_Drug_or_Biological2": "Invokana", "Contextual_Information": ""}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Novo Nordisk Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000144", "Total_Amount_of_Payment_USDollars": "10.10", "Date_of_Payment": "09/10/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "161957230", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Levemir", "Name_of_Associated_Covered_Drug_or_Biological2": "Victoza", "Contextual_Information": ""}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Takeda Pharmaceuticals America, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IL", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000339", "Total_Amount_of_Payment_USDollars": "10.09", "Date_of_Payment": "05/18/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "337228910", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Contrave", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Boehringer Ingelheim Pharmaceuticals, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CT", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000234", "Total_Amount_of_Payment_USDollars": "10.08", "Date_of_Payment": "02/05/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "290266414", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "PRADAXA", "Name_of_Associated_Covered_Drug_or_Biological2": "SPIRIVA", "Contextual_Information": ""}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Boehringer Ingelheim Pharmaceuticals, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CT", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000234", "Total_Amount_of_Payment_USDollars": "10.07", "Date_of_Payment": "03/05/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "196132654", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "SPIRIVA", "Name_of_Associated_Covered_Drug_or_Biological2": "PRADAXA", "Contextual_Information": ""}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "GlaxoSmithKline, LLC.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000005449", "Total_Amount_of_Payment_USDollars": "10.06", "Date_of_Payment": "08/28/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "197805600", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "TANZEUM", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Janssen Pharmaceuticals, Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000232", "Total_Amount_of_Payment_USDollars": "10.00", "Date_of_Payment": "01/29/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "275703774", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Xarelto", "Name_of_Associated_Covered_Drug_or_Biological2": "Invokana", "Contextual_Information": ""}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Novo Nordisk Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000144", "Total_Amount_of_Payment_USDollars": "9.90", "Date_of_Payment": "10/24/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "162404586", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Victoza", "Name_of_Associated_Covered_Drug_or_Biological2": "Levemir", "Contextual_Information": ""}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Takeda Pharmaceuticals America, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IL", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000339", "Total_Amount_of_Payment_USDollars": "9.76", "Date_of_Payment": "10/22/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "194671524", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Brintellix", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Janssen Pharmaceuticals, Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000232", "Total_Amount_of_Payment_USDollars": "9.74", "Date_of_Payment": "04/13/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "275703762", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Invokana", "Name_of_Associated_Covered_Drug_or_Biological2": "Xarelto", "Contextual_Information": ""}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "GlaxoSmithKline, LLC.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000005449", "Total_Amount_of_Payment_USDollars": "9.63", "Date_of_Payment": "04/10/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "318839112", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "ANORO", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Takeda Pharmaceuticals America, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IL", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000339", "Total_Amount_of_Payment_USDollars": "9.58", "Date_of_Payment": "06/22/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "337188766", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Uloric", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Boehringer Ingelheim Pharmaceuticals, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CT", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000234", "Total_Amount_of_Payment_USDollars": "9.55", "Date_of_Payment": "11/03/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "290266384", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "JARDIANCE", "Name_of_Associated_Covered_Drug_or_Biological2": "GLYXAMBI", "Contextual_Information": ""}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Novo Nordisk Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000144", "Total_Amount_of_Payment_USDollars": "9.51", "Date_of_Payment": "12/15/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "270247832", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "NovoLog", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "GlaxoSmithKline, LLC.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000005449", "Total_Amount_of_Payment_USDollars": "9.50", "Date_of_Payment": "10/07/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "318839236", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "TANZEUM", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "GlaxoSmithKline, LLC.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000005449", "Total_Amount_of_Payment_USDollars": "9.39", "Date_of_Payment": "01/08/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "197688728", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "BREO", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Janssen Pharmaceuticals, Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000232", "Total_Amount_of_Payment_USDollars": "9.35", "Date_of_Payment": "01/20/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "275703756", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Invokana", "Name_of_Associated_Covered_Drug_or_Biological2": "Xarelto", "Contextual_Information": ""}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "GlaxoSmithKline, LLC.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000005449", "Total_Amount_of_Payment_USDollars": "9.33", "Date_of_Payment": "12/12/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "197827778", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "ANORO", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Boehringer Ingelheim Pharmaceuticals, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CT", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000234", "Total_Amount_of_Payment_USDollars": "9.27", "Date_of_Payment": "06/25/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "290266404", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "PRADAXA", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Janssen Pharmaceuticals, Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000232", "Total_Amount_of_Payment_USDollars": "9.26", "Date_of_Payment": "09/29/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "275703806", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Xarelto", "Name_of_Associated_Covered_Drug_or_Biological2": "Invokana", "Contextual_Information": "Related to product discussion"}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "GlaxoSmithKline, LLC.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000005449", "Total_Amount_of_Payment_USDollars": "9.17", "Date_of_Payment": "09/05/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "197805794", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "ANORO", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Pfizer Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NY", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000286", "Total_Amount_of_Payment_USDollars": "9.17", "Date_of_Payment": "10/13/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "322679150", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "CHANTIX", "Name_of_Associated_Covered_Drug_or_Biological2": "VIAGRA", "Contextual_Information": ""}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Janssen Pharmaceuticals, Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000232", "Total_Amount_of_Payment_USDollars": "9.12", "Date_of_Payment": "11/16/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "275703770", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "XARELTO", "Name_of_Associated_Covered_Drug_or_Biological2": "INVOKANA", "Contextual_Information": "Related to product discussion"}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Pfizer Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NY", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000286", "Total_Amount_of_Payment_USDollars": "9.01", "Date_of_Payment": "06/02/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "323336304", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "ELIQUIS", "Name_of_Associated_Covered_Drug_or_Biological2": "VIAGRA", "Contextual_Information": ""}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "GlaxoSmithKline, LLC.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000005449", "Total_Amount_of_Payment_USDollars": "8.93", "Date_of_Payment": "11/12/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "318839302", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "TANZEUM", "Name_of_Associated_Covered_Drug_or_Biological2": "ANORO", "Contextual_Information": ""}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Janssen Pharmaceuticals, Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000232", "Total_Amount_of_Payment_USDollars": "8.88", "Date_of_Payment": "07/20/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "275703768", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Invokana", "Name_of_Associated_Covered_Drug_or_Biological2": "Xarelto", "Contextual_Information": "Related to product discussion"}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Novo Nordisk Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000144", "Total_Amount_of_Payment_USDollars": "8.56", "Date_of_Payment": "06/09/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "161637216", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Victoza", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Janssen Pharmaceuticals, Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000232", "Total_Amount_of_Payment_USDollars": "8.48", "Date_of_Payment": "05/19/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "275703790", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Xarelto", "Name_of_Associated_Covered_Drug_or_Biological2": "Invokana", "Contextual_Information": ""}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Pfizer Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NY", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000286", "Total_Amount_of_Payment_USDollars": "8.48", "Date_of_Payment": "10/05/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "322637817", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "PREVNAR - 13", "Name_of_Associated_Covered_Drug_or_Biological2": "TRUMENBA", "Contextual_Information": ""}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Novo Nordisk Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000144", "Total_Amount_of_Payment_USDollars": "8.45", "Date_of_Payment": "04/07/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "161072034", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "NovoLog", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Janssen Pharmaceuticals, Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000232", "Total_Amount_of_Payment_USDollars": "8.45", "Date_of_Payment": "06/08/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "275703796", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Xarelto", "Name_of_Associated_Covered_Drug_or_Biological2": "Invokana", "Contextual_Information": ""}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Janssen Pharmaceuticals, Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000232", "Total_Amount_of_Payment_USDollars": "8.45", "Date_of_Payment": "09/15/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "275703810", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Xarelto", "Name_of_Associated_Covered_Drug_or_Biological2": "Invokana", "Contextual_Information": "Related to product discussion"}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Novo Nordisk Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000144", "Total_Amount_of_Payment_USDollars": "8.32", "Date_of_Payment": "09/16/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "269974798", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Victoza", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Pfizer Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NY", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000286", "Total_Amount_of_Payment_USDollars": "8.32", "Date_of_Payment": "12/01/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "323158894", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "ELIQUIS", "Name_of_Associated_Covered_Drug_or_Biological2": "VIAGRA", "Contextual_Information": ""}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Takeda Pharmaceuticals America, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IL", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000339", "Total_Amount_of_Payment_USDollars": "8.20", "Date_of_Payment": "07/13/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "336961524", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Contrave", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Boehringer Ingelheim Pharmaceuticals, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CT", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000234", "Total_Amount_of_Payment_USDollars": "8.18", "Date_of_Payment": "11/19/2013", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "104303376", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "PRADAXA", "Name_of_Associated_Covered_Drug_or_Biological2": "COMBIVENT RESPIMAT", "Contextual_Information": ""}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Sunovion Pharmaceuticals Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "MA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000254", "Total_Amount_of_Payment_USDollars": "7.95", "Date_of_Payment": "01/24/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "163225474", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Brovana", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "GlaxoSmithKline, LLC.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000005449", "Total_Amount_of_Payment_USDollars": "7.91", "Date_of_Payment": "12/03/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "197831096", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "TANZEUM", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Takeda Pharmaceuticals America, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IL", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000339", "Total_Amount_of_Payment_USDollars": "7.79", "Date_of_Payment": "11/04/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "194671530", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Nesina", "Name_of_Associated_Covered_Drug_or_Biological2": "Oseni", "Contextual_Information": ""}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Sunovion Pharmaceuticals Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "MA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000254", "Total_Amount_of_Payment_USDollars": "7.47", "Date_of_Payment": "09/25/2013", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "101237094", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Brovana", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Takeda Pharmaceuticals America, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IL", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000339", "Total_Amount_of_Payment_USDollars": "7.02", "Date_of_Payment": "10/25/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "337421290", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Nesina", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Janssen Pharmaceuticals, Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000232", "Total_Amount_of_Payment_USDollars": "6.79", "Date_of_Payment": "04/03/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "275703784", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Xarelto", "Name_of_Associated_Covered_Drug_or_Biological2": "Invokana", "Contextual_Information": ""}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "GlaxoSmithKline, LLC.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000005449", "Total_Amount_of_Payment_USDollars": "6.62", "Date_of_Payment": "04/29/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "318839197", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "TANZEUM", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Boehringer Ingelheim Pharmaceuticals, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CT", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000234", "Total_Amount_of_Payment_USDollars": "6.61", "Date_of_Payment": "10/30/2013", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "104297790", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "SPIRIVA", "Name_of_Associated_Covered_Drug_or_Biological2": "PRADAXA", "Contextual_Information": ""}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Pfizer Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NY", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000286", "Total_Amount_of_Payment_USDollars": "6.50", "Date_of_Payment": "09/14/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "322561090", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "LYRICA", "Name_of_Associated_Covered_Drug_or_Biological2": "VIAGRA", "Contextual_Information": ""}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Boehringer Ingelheim Pharmaceuticals, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CT", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000234", "Total_Amount_of_Payment_USDollars": "6.31", "Date_of_Payment": "08/31/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "290266400", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "GLYXAMBI", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Novo Nordisk Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000144", "Total_Amount_of_Payment_USDollars": "5.96", "Date_of_Payment": "12/03/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "270116586", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Levemir", "Name_of_Associated_Covered_Drug_or_Biological2": "Victoza", "Contextual_Information": ""}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Janssen Pharmaceuticals, Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000232", "Total_Amount_of_Payment_USDollars": "5.83", "Date_of_Payment": "11/20/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "275703750", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "INVOKANA", "Name_of_Associated_Covered_Drug_or_Biological2": "XARELTO", "Contextual_Information": "Related to product discussion"}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Janssen Pharmaceuticals, Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000232", "Total_Amount_of_Payment_USDollars": "5.83", "Date_of_Payment": "01/06/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "275703778", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Xarelto", "Name_of_Associated_Covered_Drug_or_Biological2": "Invokana", "Contextual_Information": ""}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Pfizer Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NY", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000286", "Total_Amount_of_Payment_USDollars": "5.77", "Date_of_Payment": "09/30/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "323560872", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "VIAGRA", "Name_of_Associated_Covered_Drug_or_Biological2": "TOVIAZ", "Contextual_Information": ""}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Pfizer Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NY", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000286", "Total_Amount_of_Payment_USDollars": "5.77", "Date_of_Payment": "07/14/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "323927778", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "TOVIAZ", "Name_of_Associated_Covered_Drug_or_Biological2": "LYRICA", "Contextual_Information": ""}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Janssen Pharmaceuticals, Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000232", "Total_Amount_of_Payment_USDollars": "5.47", "Date_of_Payment": "10/12/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "275703814", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Xarelto", "Name_of_Associated_Covered_Drug_or_Biological2": "Invokana", "Contextual_Information": "Related to product discussion"}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Sunovion Pharmaceuticals Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "MA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000254", "Total_Amount_of_Payment_USDollars": "4.21", "Date_of_Payment": "09/25/2013", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "101237090", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Brovana", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Sunovion Pharmaceuticals Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "MA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000254", "Total_Amount_of_Payment_USDollars": "3.92", "Date_of_Payment": "01/23/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "321153427", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Brovana", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Pfizer Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NY", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000286", "Total_Amount_of_Payment_USDollars": "3.82", "Date_of_Payment": "04/20/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "322289818", "Nature_of_Payment_or_Transfer_of_Value": "Education", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "LYRICA", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Pfizer Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NY", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000286", "Total_Amount_of_Payment_USDollars": "3.82", "Date_of_Payment": "05/14/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "323670874", "Nature_of_Payment_or_Transfer_of_Value": "Education", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "LYRICA", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Pfizer Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NY", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000286", "Total_Amount_of_Payment_USDollars": "3.72", "Date_of_Payment": "09/08/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "323254318", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "PREVNAR - 13", "Name_of_Associated_Covered_Drug_or_Biological2": "TRUMENBA", "Contextual_Information": ""}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Novo Nordisk Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000144", "Total_Amount_of_Payment_USDollars": "3.00", "Date_of_Payment": "06/09/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "161633422", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Victoza", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Janssen Pharmaceuticals, Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000232", "Total_Amount_of_Payment_USDollars": "3.00", "Date_of_Payment": "04/03/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "275703788", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Xarelto", "Name_of_Associated_Covered_Drug_or_Biological2": "Invokana", "Contextual_Information": ""}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Pfizer Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NY", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000286", "Total_Amount_of_Payment_USDollars": "2.52", "Date_of_Payment": "07/14/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "322965112", "Nature_of_Payment_or_Transfer_of_Value": "Education", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "LYRICA", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Pfizer Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NY", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000286", "Total_Amount_of_Payment_USDollars": "2.52", "Date_of_Payment": "08/19/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "323200288", "Nature_of_Payment_or_Transfer_of_Value": "Education", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "LYRICA", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Sunovion Pharmaceuticals Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "MA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000254", "Total_Amount_of_Payment_USDollars": "2.42", "Date_of_Payment": "06/27/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "163222770", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Brovana", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Janssen Pharmaceuticals, Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000232", "Total_Amount_of_Payment_USDollars": "2.32", "Date_of_Payment": "01/29/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "275703776", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Xarelto", "Name_of_Associated_Covered_Drug_or_Biological2": "Invokana", "Contextual_Information": ""}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Sunovion Pharmaceuticals Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "MA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000254", "Total_Amount_of_Payment_USDollars": "1.86", "Date_of_Payment": "12/11/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "163268056", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Brovana", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Janssen Pharmaceuticals, Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000232", "Total_Amount_of_Payment_USDollars": "1.77", "Date_of_Payment": "07/07/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "275703764", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Invokana", "Name_of_Associated_Covered_Drug_or_Biological2": "Xarelto", "Contextual_Information": "Related to product discussion"}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Janssen Pharmaceuticals, Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000232", "Total_Amount_of_Payment_USDollars": "1.62", "Date_of_Payment": "07/23/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "156752460", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Xarelto", "Name_of_Associated_Covered_Drug_or_Biological2": "Invokana", "Contextual_Information": ""}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Janssen Pharmaceuticals, Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000232", "Total_Amount_of_Payment_USDollars": "1.54", "Date_of_Payment": "10/12/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "275703812", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Xarelto", "Name_of_Associated_Covered_Drug_or_Biological2": "Invokana", "Contextual_Information": "Related to product discussion"}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Boehringer Ingelheim Pharmaceuticals, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CT", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000234", "Total_Amount_of_Payment_USDollars": "1.48", "Date_of_Payment": "12/14/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "290266386", "Nature_of_Payment_or_Transfer_of_Value": "Education", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "JARDIANCE", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Sunovion Pharmaceuticals Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "MA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000254", "Total_Amount_of_Payment_USDollars": "1.35", "Date_of_Payment": "10/25/2013", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "101237088", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Brovana", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "GlaxoSmithKline, LLC.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000005449", "Total_Amount_of_Payment_USDollars": "1.31", "Date_of_Payment": "08/27/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "197805606", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "TANZEUM", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Janssen Pharmaceuticals, Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000232", "Total_Amount_of_Payment_USDollars": "1.21", "Date_of_Payment": "04/03/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "275703786", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Xarelto", "Name_of_Associated_Covered_Drug_or_Biological2": "Invokana", "Contextual_Information": ""}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Pfizer Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NY", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000286", "Total_Amount_of_Payment_USDollars": "1.21", "Date_of_Payment": "03/23/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "322801444", "Nature_of_Payment_or_Transfer_of_Value": "Education", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "LYRICA", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Novo Nordisk Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000144", "Total_Amount_of_Payment_USDollars": "1.16", "Date_of_Payment": "03/17/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "269652224", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "NovoLog", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Pfizer Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NY", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000286", "Total_Amount_of_Payment_USDollars": "1.16", "Date_of_Payment": "09/30/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "323282158", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "VIAGRA", "Name_of_Associated_Covered_Drug_or_Biological2": "TOVIAZ", "Contextual_Information": ""}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Janssen Pharmaceuticals, Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000232", "Total_Amount_of_Payment_USDollars": "1.13", "Date_of_Payment": "06/08/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "275703794", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Xarelto", "Name_of_Associated_Covered_Drug_or_Biological2": "Invokana", "Contextual_Information": ""}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Novo Nordisk Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000144", "Total_Amount_of_Payment_USDollars": "1.05", "Date_of_Payment": "03/03/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "160949698", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Levemir", "Name_of_Associated_Covered_Drug_or_Biological2": "NovoLog", "Contextual_Information": ""}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Janssen Pharmaceuticals, Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000232", "Total_Amount_of_Payment_USDollars": "1.02", "Date_of_Payment": "08/17/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "275703802", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Xarelto", "Name_of_Associated_Covered_Drug_or_Biological2": "Invokana", "Contextual_Information": "Related to product discussion"}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "GlaxoSmithKline, LLC.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000005449", "Total_Amount_of_Payment_USDollars": "0.96", "Date_of_Payment": "12/02/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "197831098", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "TANZEUM", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Janssen Pharmaceuticals, Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000232", "Total_Amount_of_Payment_USDollars": "0.94", "Date_of_Payment": "09/24/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "156752466", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Xarelto", "Name_of_Associated_Covered_Drug_or_Biological2": "Invokana", "Contextual_Information": ""}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Janssen Pharmaceuticals, Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000232", "Total_Amount_of_Payment_USDollars": "0.94", "Date_of_Payment": "12/07/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "275703754", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "INVOKANA", "Name_of_Associated_Covered_Drug_or_Biological2": "XARELTO", "Contextual_Information": "Related to product discussion"}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Janssen Pharmaceuticals, Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000232", "Total_Amount_of_Payment_USDollars": "0.87", "Date_of_Payment": "07/20/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "275703766", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Invokana", "Name_of_Associated_Covered_Drug_or_Biological2": "Xarelto", "Contextual_Information": "Related to product discussion"}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Novo Nordisk Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000144", "Total_Amount_of_Payment_USDollars": "0.83", "Date_of_Payment": "05/20/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "161339510", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Levemir", "Name_of_Associated_Covered_Drug_or_Biological2": "Victoza", "Contextual_Information": ""}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Pfizer Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NY", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000286", "Total_Amount_of_Payment_USDollars": "0.82", "Date_of_Payment": "12/01/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "323464278", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "CHANTIX", "Name_of_Associated_Covered_Drug_or_Biological2": "ELIQUIS", "Contextual_Information": ""}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Novo Nordisk Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000144", "Total_Amount_of_Payment_USDollars": "0.78", "Date_of_Payment": "02/12/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "160897288", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Levemir", "Name_of_Associated_Covered_Drug_or_Biological2": "NovoLog", "Contextual_Information": ""}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Novo Nordisk Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000144", "Total_Amount_of_Payment_USDollars": "0.78", "Date_of_Payment": "01/28/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "269589666", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Levemir", "Name_of_Associated_Covered_Drug_or_Biological2": "NovoLog", "Contextual_Information": ""}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Pfizer Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NY", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000286", "Total_Amount_of_Payment_USDollars": "0.77", "Date_of_Payment": "07/21/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "323601234", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "TRUMENBA", "Name_of_Associated_Covered_Drug_or_Biological2": "PREVNAR - 13", "Contextual_Information": ""}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Pfizer Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NY", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000286", "Total_Amount_of_Payment_USDollars": "0.73", "Date_of_Payment": "09/08/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "322312232", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "PREVNAR - 13", "Name_of_Associated_Covered_Drug_or_Biological2": "TRUMENBA", "Contextual_Information": ""}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Novo Nordisk Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000144", "Total_Amount_of_Payment_USDollars": "0.72", "Date_of_Payment": "04/07/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "161037872", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Victoza", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Pfizer Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NY", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000286", "Total_Amount_of_Payment_USDollars": "0.71", "Date_of_Payment": "08/19/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "322919008", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "LYRICA", "Name_of_Associated_Covered_Drug_or_Biological2": "TOVIAZ", "Contextual_Information": ""}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Janssen Pharmaceuticals, Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000232", "Total_Amount_of_Payment_USDollars": "0.64", "Date_of_Payment": "11/16/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "275703772", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "XARELTO", "Name_of_Associated_Covered_Drug_or_Biological2": "INVOKANA", "Contextual_Information": "Related to product discussion"}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Janssen Pharmaceuticals, Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000232", "Total_Amount_of_Payment_USDollars": "0.63", "Date_of_Payment": "09/15/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "275703808", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Xarelto", "Name_of_Associated_Covered_Drug_or_Biological2": "Invokana", "Contextual_Information": "Related to product discussion"}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Janssen Pharmaceuticals, Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000232", "Total_Amount_of_Payment_USDollars": "0.62", "Date_of_Payment": "03/09/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "275703782", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Xarelto", "Name_of_Associated_Covered_Drug_or_Biological2": "Invokana", "Contextual_Information": ""}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Pfizer Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NY", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000286", "Total_Amount_of_Payment_USDollars": "0.60", "Date_of_Payment": "02/11/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "323165990", "Nature_of_Payment_or_Transfer_of_Value": "Education", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "LYRICA", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Pfizer Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NY", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000286", "Total_Amount_of_Payment_USDollars": "0.58", "Date_of_Payment": "09/08/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "322961418", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "TRUMENBA", "Name_of_Associated_Covered_Drug_or_Biological2": "PREVNAR - 13", "Contextual_Information": ""}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Janssen Pharmaceuticals, Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000232", "Total_Amount_of_Payment_USDollars": "0.57", "Date_of_Payment": "08/07/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "156752464", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Xarelto", "Name_of_Associated_Covered_Drug_or_Biological2": "Invokana", "Contextual_Information": ""}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Sunovion Pharmaceuticals Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "MA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000254", "Total_Amount_of_Payment_USDollars": "0.56", "Date_of_Payment": "10/17/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "163279104", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Brovana", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Boehringer Ingelheim Pharmaceuticals, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CT", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000234", "Total_Amount_of_Payment_USDollars": "0.55", "Date_of_Payment": "11/19/2013", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "104278676", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "PRADAXA", "Name_of_Associated_Covered_Drug_or_Biological2": "COMBIVENT RESPIMAT", "Contextual_Information": ""}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Pfizer Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NY", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000286", "Total_Amount_of_Payment_USDollars": "0.54", "Date_of_Payment": "10/05/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "322412078", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "TRUMENBA", "Name_of_Associated_Covered_Drug_or_Biological2": "PREVNAR - 13", "Contextual_Information": ""}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "GlaxoSmithKline, LLC.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000005449", "Total_Amount_of_Payment_USDollars": "0.54", "Date_of_Payment": "04/10/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "318839139", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "ANORO", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Pfizer Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NY", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000286", "Total_Amount_of_Payment_USDollars": "0.53", "Date_of_Payment": "06/02/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "323875642", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "VIAGRA", "Name_of_Associated_Covered_Drug_or_Biological2": "ELIQUIS", "Contextual_Information": ""}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Sunovion Pharmaceuticals Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "MA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000254", "Total_Amount_of_Payment_USDollars": "0.49", "Date_of_Payment": "06/20/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "163245070", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Brovana", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Pfizer Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NY", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000286", "Total_Amount_of_Payment_USDollars": "0.49", "Date_of_Payment": "10/13/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "323189046", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "CHANTIX", "Name_of_Associated_Covered_Drug_or_Biological2": "ELIQUIS", "Contextual_Information": ""}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Pfizer Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NY", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000286", "Total_Amount_of_Payment_USDollars": "0.42", "Date_of_Payment": "01/15/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "322586223", "Nature_of_Payment_or_Transfer_of_Value": "Education", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "LYRICA", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Boehringer Ingelheim Pharmaceuticals, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CT", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000234", "Total_Amount_of_Payment_USDollars": "0.40", "Date_of_Payment": "11/18/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "196695508", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "SPIRIVA", "Name_of_Associated_Covered_Drug_or_Biological2": "PRADAXA", "Contextual_Information": ""}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Janssen Pharmaceuticals, Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000232", "Total_Amount_of_Payment_USDollars": "0.39", "Date_of_Payment": "04/13/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "275703760", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Invokana", "Name_of_Associated_Covered_Drug_or_Biological2": "Xarelto", "Contextual_Information": ""}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Janssen Pharmaceuticals, Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000232", "Total_Amount_of_Payment_USDollars": "0.35", "Date_of_Payment": "01/20/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "275703758", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Invokana", "Name_of_Associated_Covered_Drug_or_Biological2": "Xarelto", "Contextual_Information": ""}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "GlaxoSmithKline, LLC.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000005449", "Total_Amount_of_Payment_USDollars": "0.29", "Date_of_Payment": "10/06/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "318839252", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "TANZEUM", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Janssen Pharmaceuticals, Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000232", "Total_Amount_of_Payment_USDollars": "0.21", "Date_of_Payment": "05/19/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "275703792", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Xarelto", "Name_of_Associated_Covered_Drug_or_Biological2": "Invokana", "Contextual_Information": ""}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Janssen Pharmaceuticals, Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000232", "Total_Amount_of_Payment_USDollars": "0.21", "Date_of_Payment": "06/15/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "275703800", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Xarelto", "Name_of_Associated_Covered_Drug_or_Biological2": "Invokana", "Contextual_Information": ""}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Pfizer Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NY", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000286", "Total_Amount_of_Payment_USDollars": "0.17", "Date_of_Payment": "07/14/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "323492832", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "LYRICA", "Name_of_Associated_Covered_Drug_or_Biological2": "VIAGRA", "Contextual_Information": ""}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "GlaxoSmithKline, LLC.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000005449", "Total_Amount_of_Payment_USDollars": "0.17", "Date_of_Payment": "11/12/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "318839332", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "TANZEUM", "Name_of_Associated_Covered_Drug_or_Biological2": "ANORO", "Contextual_Information": ""}, {"Physician_Profile_ID": "170649", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Pfizer Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NY", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000286", "Total_Amount_of_Payment_USDollars": "0.12", "Date_of_Payment": "10/05/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "323366880", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "TRUMENBA", "Name_of_Associated_Covered_Drug_or_Biological2": "PREVNAR - 13", "Contextual_Information": ""}]